Alprostadil

Active ingredient description

Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Alprostadil
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EA Prostaglandins
Discover more medicines within C01EA01
Alprostadil
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE01

Medicines

Alprostadil is the active ingredient of these drugs:

Drug
Countries

Austria

Austria

Australia Austria Brazil Canada Cyprus

France Tunisia United States

Austria

Austria Canada Finland Ireland Lithuania

Austria

Austria Brazil Poland

Canada Hong Kong Netherlands New Zealand Poland

France

Finland

Lithuania

United Kingdom

Spain

Austria Cyprus Finland France Ireland

Poland

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

F5TD010360 - ALPROSTADIL

CAS registry number

745-65-3 - alprostadil

SNOMED-CT

386972003 - Alprostadil (substance)

48988008 - Alprostadil (substance)